<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>米内网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-13T16:58:36+08:00</updated>
  <subtitle>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>千亿市场新药来袭，豪森获批，齐鲁、绿叶冲刺！石药猛攻脂质体，口溶膜成大热</title>
    <updated>2021-01-13T16:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/GDYQMqUJRCApIdancawUpg</id>
    <link href="https://mp.weixin.qq.com/s/GDYQMqUJRCApIdancawUpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】四川药企将拿下30亿抗肿瘤注射剂，赛诺菲占六成市场</title>
    <updated>2021-01-13T16:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/AumjX9PgNEy2rDl7719B1Q</id>
    <link href="https://mp.weixin.qq.com/s/AumjX9PgNEy2rDl7719B1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】输液龙头发威！注射剂新品将获批，与丽珠围攻原研</title>
    <updated>2021-01-13T16:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/Y1FWJiQwG4-NhxMUOCnwig</id>
    <link href="https://mp.weixin.qq.com/s/Y1FWJiQwG4-NhxMUOCnwig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【火爆】600+大咖齐聚IDC2021化学创新药研发与分析论坛</title>
    <updated>2021-01-13T16:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/6HMuq6TyrjlRpQaJ8vPztw</id>
    <link href="https://mp.weixin.qq.com/s/6HMuq6TyrjlRpQaJ8vPztw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中成药TOP20出炉！17个独家产品霸屏，3大品牌逆势增长，扬子江、康缘……抢食百亿市场</title>
    <updated>2021-01-12T17:03:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/_UjAf9milCCpz_JDnszkog</id>
    <link href="https://mp.weixin.qq.com/s/_UjAf9milCCpz_JDnszkog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【获批】30亿注射剂！奥赛康、朗天同日过评，阿斯利康失守半壁江山</title>
    <updated>2021-01-12T17:03:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/xYCmWw3lu_ncAkpPYAlZ-Q</id>
    <link href="https://mp.weixin.qq.com/s/xYCmWw3lu_ncAkpPYAlZ-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】银屑病“新星”本维莫德首进医保目录，外用治疗将迎新变革</title>
    <updated>2021-01-12T17:03:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/a7j791VHwMpabuOAbhFPZg</id>
    <link href="https://mp.weixin.qq.com/s/a7j791VHwMpabuOAbhFPZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【FDA】12月7款创新药来袭！2020年超50款获批上市</title>
    <updated>2021-01-12T17:03:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/Q-2fM91Oucr6r3fNHQQbKw</id>
    <link href="https://mp.weixin.qq.com/s/Q-2fM91Oucr6r3fNHQQbKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴、扬子江、科伦……84款注射剂过评！TOP10企业出炉，3大千亿市场遭“围攻”</title>
    <updated>2021-01-11T16:12:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/iqoj7HbGX2XkoC5DV5mRhA</id>
    <link href="https://mp.weixin.qq.com/s/iqoj7HbGX2XkoC5DV5mRhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【热议】“中道合盟”正式成立，华润江中联合渠道伙伴，共创医药商业合作新模式</title>
    <updated>2021-01-11T16:12:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/5912b5KcGRGYxv3b43KXxA</id>
    <link href="https://mp.weixin.qq.com/s/5912b5KcGRGYxv3b43KXxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】齐鲁又有1类新药来袭，首款口溶膜将获批</title>
    <updated>2021-01-11T16:12:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/qZryEaBZdwwg4vA1sRrM8A</id>
    <link href="https://mp.weixin.qq.com/s/qZryEaBZdwwg4vA1sRrM8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】35亿注射剂大品种，恒瑞将拿下首仿</title>
    <updated>2021-01-11T16:12:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/BCmTGZ6lYeTCvJaSIQ4yBQ</id>
    <link href="https://mp.weixin.qq.com/s/BCmTGZ6lYeTCvJaSIQ4yBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科伦、扬子江......57个新药报临床！正大天晴首个吸入剂1类新药亮相，齐鲁首款口溶膜来了</title>
    <updated>2021-01-10T07:58:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/zLII2soeFLr9L0z-CbvbJQ</id>
    <link href="https://mp.weixin.qq.com/s/zLII2soeFLr9L0z-CbvbJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辅助用药、中药、抗菌药压力大增！“东北茅台”冲上2000亿，科伦仿制药放量</title>
    <updated>2021-01-09T08:10:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/AI6Ug2COKCd5RheL2aWa-Q</id>
    <link href="https://mp.weixin.qq.com/s/AI6Ug2COKCd5RheL2aWa-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百亿眼科用药市场“激战”！恒瑞、齐鲁抢首仿，兴齐眼药冲击10亿大品种，TOP10排位生变</title>
    <updated>2021-01-08T17:05:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/I9XIw13A_K1mnII1Gnaljg</id>
    <link href="https://mp.weixin.qq.com/s/I9XIw13A_K1mnII1Gnaljg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【获批】东阳光药拿下6亿抗抑郁药！恩华、齐鲁3家药企也来了</title>
    <updated>2021-01-08T17:05:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/_q5M57tvds7EaYUauciaHw</id>
    <link href="https://mp.weixin.qq.com/s/_q5M57tvds7EaYUauciaHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】研发费用近4亿！恒瑞25亿抗肿瘤药再下一城</title>
    <updated>2021-01-08T17:05:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/gUiVB9nbtHQz98DYhlSTZQ</id>
    <link href="https://mp.weixin.qq.com/s/gUiVB9nbtHQz98DYhlSTZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【审评】扬子江、健康元……瞄准超5亿吸入剂！原研药六成市场告急</title>
    <updated>2021-01-08T17:05:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/-gyCxXy6wL4HaQhd6YaJrA</id>
    <link href="https://mp.weixin.qq.com/s/-gyCxXy6wL4HaQhd6YaJrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>吸入剂首次国采！国产品牌耀眼，46个品种过评提速，正大天晴、倍特......冲刺16个首仿</title>
    <updated>2021-01-07T15:55:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/st8r5wr9BjMFUd1XaPhKfw</id>
    <link href="https://mp.weixin.qq.com/s/st8r5wr9BjMFUd1XaPhKfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】扬子江将拿下19亿麻醉剂，原研药六成市场不保</title>
    <updated>2021-01-07T15:55:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/bEPqPda2DEVCL3hmGde92Q</id>
    <link href="https://mp.weixin.qq.com/s/bEPqPda2DEVCL3hmGde92Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>